NDC 73309-077-01 - D-Penicillamine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 73309-077
- Requested NDC
- 73309-077-01
- Package NDCs from labels
- 73309-077-01
- Manufacturer
- BLUEBAY SHANDONG CO.,LTD
- Effective date
- 2020-01-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| D-Penicillamine - BLUEBAY SHANDONG CO.,LTD | BLUEBAY SHANDONG CO.,LTD | 2020-01-10 | BULK INGREDIENT |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73309-077-01 | D-Penicillamine | 1 kg in 1 JAR | POWDER | 1 | 1 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Penicillamine | PENICILLAMINE | Breckenridge Pharmaceutical, Inc. | 1320f46b-e243-4e93-b9c9-ad8eb7828de5 | 2026-08-14 | Boxed warning, Warnings, Adverse reactions | GNN1DV99GX |
| penicillamine | PENICILLAMINE | Par Health USA, LLC | 72ee469c-f9ef-4bb4-922f-5d71276664a5 | 2026-07-31 | Warnings, Adverse reactions | GNN1DV99GX |
| Penicillamine | PENICILLAMINE | Par Health USA, LLC | 01e79d8f-8c74-4f48-b761-9f225fabf93d | 2026-07-23 | Boxed warning, Warnings, Adverse reactions | GNN1DV99GX |
| Cuprimine | PENICILLAMINE | Bausch Health US, LLC | 80e736d3-2017-4d68-94b4-38255c3c59c6 | 2026-01-26 | Boxed warning, Warnings, Adverse reactions | GNN1DV99GX |
| Depen | PENICILLAMINE | Viatris Specialty LLC | 38f8ae60-b354-11de-8a39-0800200c9a66 | 2025-09-21 | Boxed warning, Warnings, Adverse reactions | GNN1DV99GX |
| AAGYLUR | PENICILLAMINE | Cycle Pharmaceuticals Ltd. | ddbd84a9-1c39-42e0-a271-138784e1dc58 | 2024-10-01 | Boxed warning, Warnings, Adverse reactions | GNN1DV99GX |
| Penicillamine | PENICILLAMINE | Actavis Pharma, Inc. | 594d7a82-af1d-41c4-98ee-0ea6895fc237 | 2024-09-25 | Boxed warning, Warnings, Adverse reactions | GNN1DV99GX |
| Penicillamine | PENICILLAMINE | Lupin Pharmaceuticals, Inc. | f6ecaf47-902f-4378-b524-7a88f20ba138 | 2022-12-28 | Boxed warning, Warnings, Adverse reactions | GNN1DV99GX |
| Penicillamine | PENICILLAMINE | Navinta LLC | 064fb48d-aa34-4e52-9295-10f2ca4c77dc | 2022-12-02 | Warnings, Adverse reactions | GNN1DV99GX |
| Penicillamine | PENICILLAMINE | Proficient Rx LP | c92335c6-f6fa-4768-9401-55c6b7f87699 | 2022-04-01 | Boxed warning, Warnings, Adverse reactions | GNN1DV99GX |
| Penicillamine | PENICILLAMINE | Dr. Reddy's Laboratories Inc. | 15d08594-83a9-cc7a-92ef-1bac0427e121 | 2020-08-05 | Boxed warning, Warnings, Adverse reactions | GNN1DV99GX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.